| Investor | Ingalls & Snyder Llc |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Ingalls & Snyder Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | 13G/A | STRS / Stratus Properties Inc. | 1,092,084 | 1,089,538 | ||||
| 2026-04-23 | 13G/A | OMER / Omeros Corporation | 4,161,315 | 3,466,268 | ||||
| 2026-04-23 | 13G/A | HYFT / MindWalk Holdings Corp. | 2,729,122 | |||||
| 2026-04-23 | 13G | AERG / Applied Energetics, Inc. | 18,158,048 | 17,230,596 | ||||
| 2026-04-21 | 13G/A | CORT / Corcept Therapeutics Incorporated | 8,173,721 | 7,263,466 | ||||
| 2025-02-21 | 13G/A | OMER / Omeros Corporation | 4,431,188 | 4,161,315 | ||||
| 2025-02-21 | 13G/A | DRRX / DURECT Corporation | 2,558,012 | 2,681,770 | ||||
| 2025-02-21 | 13G/A | CORT / Corcept Therapeutics Incorporated | 8,262,476 | 8,173,721 | ||||
| 2025-02-21 | 13G/A | STRS / Stratus Properties Inc. | 981,057 | 1,092,084 | ||||
| 2025-02-14 | 13G/A | AERG / Applied Energetics, Inc. | 18,580,236 | 18,158,048 | ||||
| 2024-03-27 | 13G | DRRX / DURECT Corporation | 7,707,372 | 2,558,012 | ||||
| 2024-03-27 | 13G/A | STRS / Stratus Properties Inc. | 1,108,040 | 981,057 | ||||
| 2024-03-27 | 13G/A | OMER / Omeros Corporation | 4,131,793 | 4,431,188 | ||||
| 2024-03-27 | 13G/A | AERG / Applied Energetics, Inc. | 25,057,965 | 18,580,236 | ||||
| 2024-03-27 | 13G/A | CORT / Corcept Therapeutics Incorporated | 7,090,370 | 8,262,476 | ||||
| 2024-02-27 | 13G | IPA / ImmunoPrecise Antibodies Ltd. | 1,053,186 | 1,317,819 | ||||
| 2023-07-07 | 13D | IPA / ImmunoPrecise Antibodies Ltd. | 1,053,186 | |||||
| 2023-02-17 | 13G/A | STRS / Stratus Properties Inc. | 1,159,066 | 1,108,040 | ||||
| 2023-02-17 | 13G/A | OMER / Omeros Corporation | 4,464,492 | 4,131,793 | ||||
| 2023-02-17 | 13G/A | CORT / Corcept Therapeutics Incorporated | 6,655,977 | 7,090,370 | ||||
| 2023-02-17 | 13G/A | AERG / Applied Energetics, Inc. | 16,864,104 | 25,057,965 | ||||
| 2022-02-04 | 13G | AERG / Applied Energetics, Inc. | 16,864,104 | |||||
| 2022-02-04 | 13G/A | STRS / Stratus Properties Inc. | 1,239,896 | 1,159,066 | ||||
| 2022-02-04 | 13G/A | OMER / Omeros Corporation | 4,748,189 | 4,464,492 | ||||
| 2022-02-04 | 13G/A | CORT / Corcept Therapeutics Incorporated | 7,583,772 | 6,655,977 | ||||
| 2021-11-22 | 13D/A | INUV / Inuvo, Inc. | 5,250,109 | 5,621,023 | ||||
| 2021-02-09 | 13G/A | STRS / Stratus Properties Inc. | 1,281,013 | 1,239,896 | ||||
| 2021-02-09 | 13G/A | OMER / Omeros Corporation | 5,030,671 | 4,748,189 | ||||
| 2021-02-09 | 13G/A | CORT / Corcept Therapeutics Incorporated | 8,285,930 | 7,583,772 | ||||
| 2021-02-09 | 13G/A | CNCE / Concert Pharmaceuticals Inc | 1,464,712 | 1,396,003 | ||||
| 2021-02-01 | 13D/A | INUV / Inuvo, Inc. | 5,402,486 | 5,250,109 | ||||
| 2020-02-28 | 13D/A | INUV / Inuvo, Inc. | 4,201,992 | 5,402,486 | ||||
| 2020-02-07 | 13G/A | CORT / Corcept Therapeutics Incorporated | 8,643,023 | 8,285,930 | ||||
| 2020-02-07 | 13G/A | OMER / Omeros Corporation | 5,582,273 | 5,030,671 | ||||
| 2020-02-07 | 13G/A | USAS / Americas Gold and Silver Corporation | 4,089,626 | 3,141,726 | ||||
| 2020-02-07 | 13G/A | STRS / Stratus Properties Inc. | 1,461,000 | 1,281,013 | ||||
| 2020-02-07 | 13G/A | MOSY / Mosys Inc | 4,302,436 | 314,423 | ||||
| 2020-01-23 | 13G/A | DRRX / DURECT Corporation | 8,372,421 | 7,707,372 | ||||
| 2020-01-23 | 13G/A | CNCE / Concert Pharmaceuticals Inc | 1,199,775 | 1,464,712 | ||||
| 2019-07-19 | 13D | INUV / Inuvo, Inc. | 2,349,471 | 4,201,992 | ||||
| 2019-01-30 | 13G/A | OMER / Omeros Corporation | 5,714,180 | 5,582,273 | ||||
| 2019-01-30 | 13G/A | STRS / Stratus Properties Inc. | 1,517,020 | 1,461,000 | ||||
| 2019-01-30 | 13G/A | MOSY / Mosys Inc | 3,644,050 | 4,302,436 | ||||
| 2019-01-30 | 13G/A | CNCE / Concert Pharmaceuticals Inc | 1,332,662 | 1,199,775 | ||||
| 2019-01-30 | 13G/A | CORT / Corcept Therapeutics Incorporated | 7,217,724 | 8,643,023 | ||||
| 2019-01-30 | 13G/A | DRRX / DURECT Corporation | 8,486,721 | 8,372,421 | ||||
| 2019-01-30 | 13G/A | USAPF / Americas Silver Corporation | 4,185,409 | 4,089,626 | ||||
| 2018-10-30 | 13G/A | MOSY / Mosys Inc | 888,048 | 3,644,050 | ||||
| 2018-06-26 | 13D | INUV / Inuvo, Inc. | 2,349,471 | |||||
| 2018-05-11 | 13G/A | MOSY / Mosys Inc | 836,488 | 888,048 | ||||
| 2018-02-09 | 13G | CNCE / Concert Pharmaceuticals Inc | 1,332,662 | |||||
| 2018-02-09 | 13G | DRRX / DURECT Corporation | 8,486,721 | |||||
| 2018-02-09 | 13G/A | OMER / Omeros Corporation | 5,097,510 | 5,714,180 | ||||
| 2018-02-09 | 13G/A | USAPF / Americas Silver Corporation | 2,764,808 | 4,185,409 | ||||
| 2018-02-09 | 13G/A | MOSY / Mosys Inc | 15,574,018 | 836,488 | ||||
| 2018-02-09 | 13G/A | STRS / Stratus Properties Inc. | 1,370,302 | 1,517,020 | ||||
| 2018-02-08 | 13G/A | CORT / Corcept Therapeutics Incorporated | 8,083,697 | 7,217,724 | ||||
| 2017-02-15 | 13G | USAPF / Americas Silver Corporation | 2,764,808 | |||||
| 2017-02-14 | 13G/A | GTY / Getty Realty Corp. | 1,821,331 | 1,016,835 | ||||
| 2017-02-14 | 13G/A | STRS / Stratus Properties Inc. | 1,381,396 | 1,370,302 | ||||
| 2017-02-14 | 13G/A | MOSY / Mosys Inc | 15,123,336 | 15,574,018 | ||||
| 2017-02-14 | 13G/A | OMER / Omeros Corporation | 3,760,620 | 5,097,510 | ||||
| 2017-02-14 | 13G/A | CORT / Corcept Therapeutics Incorporated | 8,933,637 | 8,083,697 | ||||
| 2016-03-22 | 13G/A | MOSY / Mosys Inc | 9,668,781 | 15,123,336 | ||||
| 2016-02-19 | 13G | GTY / Getty Realty Corp. | 1,821,331 | 1,821,331 | ||||
| 2016-02-09 | 13G | GTY / Getty Realty Corp. | 1,821,331 | |||||
| 2016-02-09 | 13G/A | CORT / Corcept Therapeutics Incorporated | 8,933,637 | |||||
| 2016-02-05 | 13G/A | MOSY / Mosys Inc | 8,794,050 | 9,668,781 | ||||
| 2016-02-05 | 13G/A | STRS / Stratus Properties Inc. | 1,381,396 | |||||
| 2016-02-05 | 13G/A | OMER / Omeros Corporation | 3,760,620 | |||||
| 2015-03-05 | 13G/A | MOSY / Mosys Inc | 8,794,050 | |||||
| 2015-02-06 | 13G/A | ASRT / Assertio Holdings, Inc. | 750 | |||||
| 2015-02-06 | 13G/A | STRS / Stratus Properties Inc. | 1,340,819 | |||||
| 2015-02-06 | 13G/A | AGEN / Agenus Inc. | 0 | |||||
| 2015-02-06 | 13G/A | CORT / Corcept Therapeutics Incorporated | 7,772,745 | |||||
| 2015-02-06 | 13G/A | OMER / Omeros Corporation | 2,347,987 | |||||
| 2015-02-06 | 13G/A | MOSY / Mosys Inc | 7,822,050 | |||||
| 2015-02-06 | 13G/A | THTX / Theratechnologies Inc. | 1,949,000 | |||||
| 2014-09-12 | 13G/A | AVNR / Avanir Pharmaceuticals Inc | 6,575,201 | |||||
| 2014-04-01 | 13G/A | OMER / Omeros Corporation | 1,717,860 | |||||
| 2014-02-07 | 13G/A | ASRT / Assertio Holdings, Inc. | 4,381,750 | |||||
| 2014-02-07 | 13G/A | CORT / Corcept Therapeutics Incorporated | 6,043,804 | |||||
| 2014-02-07 | 13G/A | AGEN / Agenus Inc. | 2,000,000 | |||||
| 2014-02-07 | 13G/A | THTX / Theratechnologies Inc. | 4,652,205 | |||||
| 2014-02-07 | 13G/A | AVNR / Avanir Pharmaceuticals Inc | 11,118,891 | |||||
| 2014-02-07 | 13G/A | STRS / Stratus Properties Inc. | 1,298,549 | |||||
| 2014-02-07 | 13G/A | MOSY / Mosys Inc | 6,033,789 | |||||
| 2013-07-11 | 13G/A | OMER / Omeros Corporation | 1,293,985 | |||||
| 2013-04-18 | 13G | AGEN / Agenus Inc. | 2,116,034 | |||||
| 2013-04-11 | 13G | OMER / Omeros Corporation | 1,322,885 | |||||
| 2013-01-28 | 13G/A | ASRT / Assertio Holdings, Inc. | 4,516,750 | |||||
| 2013-01-28 | 13G/A | CORT / Corcept Therapeutics Incorporated | 5,847,151 | |||||
| 2013-01-28 | 13G/A | THTX / Theratechnologies Inc. | 6,515,325 | |||||
| 2013-01-28 | 13G/A | 1,418,663 | ||||||
| 2013-01-28 | 13G/A | AVNR / Avanir Pharmaceuticals Inc | 12,844,885 | |||||
| 2013-01-28 | 13G/A | STRS / Stratus Properties Inc. | 1,285,069 | |||||
| 2013-01-28 | 13G/A | MOSY / Mosys Inc | 5,064,242 | |||||
| 2013-01-28 | 13G/A | ALSE / Alseres Pharmaceuticals, Inc. | 100,000 | |||||
| 2012-08-31 | 13G/A | DCO / Ducommun Incorporated | 523,608 | |||||
| 2012-08-17 | 13G/A | SOMX / Somaxon Pharmaceuticals, Inc. | 2,357,500 | |||||
| 2012-08-17 | 13G | DCO / Ducommun Incorporated | 542,858 | |||||
| 2012-08-06 | 13G/A | SOMX / Somaxon Pharmaceuticals, Inc. | 4,595,000 | |||||
| 2012-03-20 | 13G/A | AGEN / Agenus Inc. | 1,001,422 | |||||
| 2012-02-07 | 13G/A | ASRT / Assertio Holdings, Inc. | 3,469,000 | |||||
| 2012-02-07 | 13G/A | MSW / Ming Shing Group Holdings Limited | 1,764,610 | |||||
| 2012-02-07 | 13G/A | CORT / Corcept Therapeutics Incorporated | 4,998,552 | |||||
| 2012-02-07 | 13G/A | AGEN / Agenus Inc. | 1,282,517 | |||||
| 2012-02-07 | 13G/A | SOMX / Somaxon Pharmaceuticals, Inc. | 5,957,000 | |||||
| 2012-02-07 | 13G/A | THTX / Theratechnologies Inc. | 6,127,045 | |||||
| 2012-02-07 | 13G/A | 1,800,926 | ||||||
| 2012-02-07 | 13G/A | AVNR / Avanir Pharmaceuticals Inc | 13,715,140 | |||||
| 2012-02-07 | 13G/A | STRS / Stratus Properties Inc. | 1,344,838 | |||||
| 2012-02-07 | 13G/A | MOSY / Mosys Inc | 4,144,992 | |||||
| 2012-02-07 | 13G/A | ALSE / Alseres Pharmaceuticals, Inc. | 3,403,969 |
